Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|September 1, 1994
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma GroupG H Jackson, A L Lennard, P R Taylor, et al.
Leukemia & Lymphoma|March 14, 1998
Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UKG H Jackson, A Wood, P R Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2003
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)S J Proctor, G H Jackson, A Lennard, et al.
Bone Marrow Transplantation|March 14, 2000
Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemiaJ Cavet, A Lennard, A Gascoigne, et al.
Leukemia|August 1, 1997
The use of an all oral chemotherapy (idarubicin and etoposide) in the treatment of acute myeloid leukaemia in the elderly: a report of toxicity and efficacyG H Jackson, P R Taylor, A Iqbal, et al.
Leukemia|August 1, 1991
Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukemiaP G Middleton, R A Prince, I K Williamson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)S J Proctor, M Mackie, A Dawson, et al.
International Journal of Laboratory Hematology|February 21, 2008
British Society for Haematology, Slide session, Annual Scientific Meeting, Bournemouth, 2007M Bhavnani, J Braithwaite, J Burthem, et al.
Leukemia & Lymphoma|November 17, 2006
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trialP R A Taylor, J M White, R J Prescott, et al.
Blood Cancer Journal|March 19, 2024
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometryH V Giles, M T Drayson, B Kishore, et al.
Pageof 8